Satellos Bioscience's total assets for Q3 2024 were C$24.21M, a decrease of -27.07% from the previous quarter. MSCLF total liabilities were C$3.62M for the fiscal quarter, a -10.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.